Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...